Lv43
436 积分 2023-05-10 加入
MYC in cancer: from undruggable target to clinical trials
12天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
13天前
已完结
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease
14天前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
14天前
已完结
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia
27天前
已完结
Molecular glue meets antibody: next-generation antibody–drug conjugates
28天前
已完结
Understanding rheumatic disease through continuous cell state analysis
28天前
已完结
Machine learning in preclinical drug discovery
28天前
已完结
Advancing targeted protein degradation for cancer therapy
28天前
已完结
Oral miniproteins treat IBD
30天前
已完结
皖公网安备34019202002308
